A Review of the Clinical Effectiveness and Cost-Effectiveness of Routine anti-D Prophylaxis for Pregnant Women Who Are Rhesus-Negative

Health Technol Assess. 2003;7(4):iii-62. doi: 10.3310/hta7040.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Erythroblastosis, Fetal / economics
  • Erythroblastosis, Fetal / immunology
  • Erythroblastosis, Fetal / prevention & control*
  • Female
  • Humans
  • Isoantibodies / immunology
  • Pregnancy
  • Pregnancy Complications, Hematologic / economics
  • Pregnancy Complications, Hematologic / prevention & control*
  • Rh-Hr Blood-Group System / immunology
  • Rho(D) Immune Globulin / economics*
  • Rho(D) Immune Globulin / therapeutic use*
  • United Kingdom

Substances

  • Isoantibodies
  • RHO(D) antibody
  • Rh-Hr Blood-Group System
  • Rho(D) Immune Globulin